FDA rejection of Oluvorofim underscores need for new antifungals.

WHO lists 19 priority fungi, including drug-resistant Candida auris

Fungicide overuse in agriculture fuels fungal resistance

FDA and EPA collaboration vital for effective antifungals

Promising drugs like Oluvorofim offer hope against fungal infections